Literature DB >> 2297486

Long-term somatic side-effects and morbidity in testicular cancer patients.

N Aass1, S Kaasa, E Lund, O Kaalhus, M S Heier, S D Fosså.   

Abstract

In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side-effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory 'neuropathy' was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred.

Entities:  

Mesh:

Year:  1990        PMID: 2297486      PMCID: PMC1971317          DOI: 10.1038/bjc.1990.31

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

Review 1.  Bleomycin and pulmonary toxicity.

Authors:  P W Van Barneveld; N H Mulder; T W Van der Mark; D T Sleijfer
Journal:  Neth J Med       Date:  1985       Impact factor: 1.422

2.  Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production.

Authors:  S D Fosså; S Ous; T Abyholm; N Norman; M Loeb
Journal:  Br J Urol       Date:  1985-04

3.  Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave Roussy from 1972 to 1982.

Authors:  D Gallez-Marchal; M Fayolle; M Henry-Amar; J P Le Bourgeois; P Rougier; J M Cosset
Journal:  Radiother Oncol       Date:  1984-08       Impact factor: 6.280

4.  [Gastrointestinal symptoms among 40-year olds in Glostrup. An epidemiological study].

Authors:  H Hollnagel; N Nørrelund; S Larsen
Journal:  Ugeskr Laeger       Date:  1982-01-25

5.  Patterns of care outcome studies: results of the national practice in seminoma of the testis.

Authors:  G E Hanks; D F Herring; S Kramer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-10       Impact factor: 7.038

6.  Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency.

Authors:  S D Fosså; S Ous; T Abyholm; M Loeb
Journal:  Br J Urol       Date:  1985-04

Review 7.  Drugs five years later. Cisplatin.

Authors:  P J Loehrer; L H Einhorn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

8.  Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.

Authors:  N J Vogelzang; G J Bosl; K Johnson; B J Kennedy
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

9.  Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.

Authors:  N J Vogelzang; J L Torkelson; B J Kennedy
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

10.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

Authors:  S D Williams; R Birch; L H Einhorn; L Irwin; F A Greco; P J Loehrer
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

View more
  12 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Advances in the treatment of testicular cancer.

Authors:  Hans-Georg Kopp; Markus Kuczyk; Johannes Classen; Arnulf Stenzl; Lothar Kanz; Frank Mayer; Michael Bamberg; Jörg Thomas Hartmann
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

4.  Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.

Authors:  Mette Sprauten; Thomas H Darrah; Derick R Peterson; M Ellen Campbell; Robyn E Hannigan; Milada Cvancarova; Clair Beard; Hege S Haugnes; Sophie D Fosså; Jan Oldenburg; Lois B Travis
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

5.  The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.

Authors:  Lene Thorsen; Wenche Nystad; Hein Stigum; Olav Dahl; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Sophie D Fosså
Journal:  Support Care Cancer       Date:  2005-03-09       Impact factor: 3.603

Review 6.  Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

Authors:  Lois B Travis; Sophie D Fossa; Howard D Sesso; Robert D Frisina; David N Herrmann; Clair J Beard; Darren R Feldman; Lance C Pagliaro; Robert C Miller; David J Vaughn; Lawrence H Einhorn; Nancy J Cox; M Eileen Dolan
Journal:  J Natl Cancer Inst       Date:  2014-03-12       Impact factor: 13.506

7.  Renal function related to different treatment modalities for malignant germ cell tumours.

Authors:  N Aass; S D Fosså; M Aas; M W Lindegaard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.

Authors:  M S Heier; T Nilsen; V Graver; N Aass; S D Fosså
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

9.  Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Authors:  Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik A Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

10.  Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).

Authors:  Chunkit Fung; David J Vaughn; Nandita Mitra; Stephanie L Ciosek; Saran Vardhanabhuti; Katherine L Nathanson; Peter A Kanetsky
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.